Trials / Completed
CompletedNCT00056472
Study of Pharmacotherapy of Psychotic Depression
Effectiveness of Selective Serotonin Reuptake Inhibitors Combined With Antipsychotic Medication for the Treatment of Psychotic Depression
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 259 (actual)
- Sponsor
- Weill Medical College of Cornell University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will determine the effectiveness of combining selective serotonin reuptake inhibitors (SSRIs) with antipsychotic medications in the treatment of psychotic depression.
Detailed description
Approximately 25% of people who are admitted to hospitals for depression suffer from psychotic depression. People with psychotic depression experience hallucinations,and, more commonly delusions, in addition to major depression. Psychotic experiences may be either congruent with the theme of depression or incongruent, without an apparent relationship to feeling depressed. This study will determine the effectiveness of combining a selective serotonin reuptake inhibitor (SSRI) with antipsychotic medication in the treatment of psychotic depression accompanied by at least one identifiable delusion. The study will also evaluate the difference in treatment response of young adults versus geriatric patients. This double-blind study will last a total of 12 weeks. Participants will be randomly assigned to receive either olanzapine, an atypical antipsychotic drug, combined with sertraline, an SSRI, or olanzapine alone. Following baseline assessments, study visits will occur weekly until Week 6, and then bi-weekly until Week 12. Participants who do not respond to either treatment may leave the study at any time. Participants who achieve either partial or full response may participate in an additional 20-week study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olanzapine | 10-20mg/day |
| DRUG | Sertraline | 150-200mg/day |
| OTHER | placebo | tablet that ressembles sertraline but contains no medication |
Timeline
- Start date
- 2003-01-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2003-03-17
- Last updated
- 2013-08-02
- Results posted
- 2013-08-02
Locations
4 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00056472. Inclusion in this directory is not an endorsement.